Use of drug effect interaction modeling with Monte Carlo simulation to examine the impact of dosing interval on the projected antiviral activity of the combination of abacavir and amprenavir.

Source:http://linkedlifedata.com/resource/pubmed/id/10817724

Download in:

View as

General Info

PMID
10817724